GRIFOLS reported €771.1M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Alcon AG ALC:SW 890M 36M
Amadeus IT AMS:SM € 102M 27M
Amarin AMRN:US $ 32.16M 3.83M
AstraZeneca AZN:LN 2193M 273M
Bayer BAYN:GR € 4546M 152M
Fresenius FRE:GR € 6628M 102M
Fresenius Medical Care FME:GR € 3036M 33M
GlaxoSmithKline GSK:LN 2519M 108M
GRIFOLS GRF:SM € 771.1M 119.7M
H. Lundbeck A/S LUN:DC 851M 513M
Hikma Pharmaceutical HIK:LN 600M 2M
Merck MRK:GR € 1813M 92M
Novartis NOVN:VX SF 3754M 79M
Philips PHIA:NA € 2441M 101M
William Demant Holding WDH:DC 2.29B 12M